Lactic acid–induced FBXL6 promotes NLRP3 inflammasome activation through activation of JNK signaling pathway in gastric cancer
F-box and leucine-rich repeat protein 6 (FBXL6), an essential component of the ubiquitin–proteasome system, regulates diverse cellular processes; however, its specific role in gastric cancer remains uncertain. This study aimed to elucidate the molecular mechanisms by which FBXL6 regulates gastric cancer cell growth, with a particular focus on its involvement in NLRP3 inflammasome activation. The potential involvement of FBXL6 in gastric cancer-related molecular pathways was first investigated using gene set enrichment analysis. Functional validation was performed in two gastric cancer cell lines (MKN45 and MKN28), a nude mouse xenograft model, and a gastric cancer tissue microarray by assessing cell proliferation, cell cycle progression, and the interactions of FBXL6 with dual-specificity phosphatase 6 (DUSP6), the c-Jun N-terminal kinase (JNK) pathway, and NLRP3 inflammasome activation. FBXL6 silencing suppressed cell growth, NLRP3 inflammasome activation, and JNK phosphorylation in MKN45 cells. In MKN28 cells, FBXL6 overexpression induced activation of NLRP3 inflammasome and increased intracellular LDH activity and lactic acid release, which were reversed by the JNK inhibitor SP600125, and its growth-promoting effect was counteracted by the NLRP3 inflammasome inhibitor MCC950. Mechanistically, FBXL6 downregulated DUSP6 expression by promoting its ubiquitination. Moreover, lactic acid-mediated H3K18 lactylation promoted FBXL6 transcription, thereby activating JNK signaling. The role of the FBXL6–DUSP6–JNK axis in tumor development was further validated in a nude mouse xenograft model. Collectively, our findings identify FBXL6 as a potential oncogene factor in gastric cancer via ubiquitination of DUSP6 to promote JNK signaling and NLRP3 inflammasome activation, highlighting the potential positive feedback loop of lactate–FBXL6–DUSP6–JNK as a promising therapeutic strategy for gastric cancer.
Authors
- 朱侃恺
- Hang Yu (ORCID: https://orcid.org/0000-0002-1798-2288)
- Chunhui Shou (ORCID: https://orcid.org/0000-0001-7381-9322)
- Xiaofeng Chu
- Xiaosun Liu
- Hailong Jin
- Yang Dong
- Xiaokun Liu
Institutions
- First People's Hospital of Yuhang District (CN)
- Hangzhou Medical College (CN)
- First Affiliated Hospital Zhejiang University (CN)
Publication Details
- Journal
- Cell Biology and Toxicology
- Published
- 2026-11-21
- DOI
- https://doi.org/10.1007/s10565-026-10369-8
- Primary Topic
- Inflammasome and immune disorders
- Type
- article
- Field-Weighted Citation Impact
- 0.00